Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    GSK fails to secure USFDA nod for HIV injection CabenuvaGSK fails to secure USFDA nod for HIV injection Cabenuva
    IceCure cryoablation technology gets USFDA nod to treat tumours in liver, kidneyIceCure cryoablation technology gets USFDA nod to treat tumours in liver, kidney
    NPPA fixes price of Cipla Synchrobreathe inhaler device; DetailsNPPA fixes price of Cipla Synchrobreathe inhaler device; Details
    Ipca Labs, Medicines for Malaria Venture ink pact for antimalarial co-formulation AtoguanilIpca Labs, Medicines for Malaria Venture ink pact for antimalarial co-formulation Atoguanil
    Lupin unveils generic equivalent of Hectorol InjectionLupin unveils generic equivalent of Hectorol Injection
    Cadila Healthcare Gujarat facility clears USFDA inspectionCadila Healthcare Gujarat facility clears USFDA inspection
    AstraZeneca-Daiichi breast cancer drug Enhertu gets speedy USFDA nodAstraZeneca-Daiichi breast cancer drug Enhertu gets speedy USFDA nod
    Novartis wins Medicaid nod for new sickle cell drug Adakveo in 2 US statesNovartis wins Medicaid nod for new sickle cell drug Adakveo in 2 US states
    Medical Devices Draft Bill 2019: Niti Ayog holds meeting with affected patients, stakeholdersMedical Devices Draft Bill 2019: Niti Ayog holds meeting with affected patients, stakeholders
    Glenmark to launch Ryaltris in Australia via partner SeqirusGlenmark to launch Ryaltris in Australia via partner Seqirus
    Lupin gets USFDA nod for generic version of Diprolene OintmentLupin gets USFDA nod for generic version of Diprolene Ointment
    Suven Life Sciences Pashamylaram facility gets EIR from USFDASuven Life Sciences Pashamylaram facility gets EIR from USFDA
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Mediclaim cannot be rejected if duplicate bills are submitted: Consumer Forum on doctors plea

    Mediclaim cannot be rejected if duplicate bills are submitted: Consumer Forum on doctors plea

    300,000 doses of Mercks Ebola shot available for emergencies: GAVI Vaccine Alliance

    300,000 doses of Merck's Ebola shot available for emergencies: GAVI Vaccine Alliance

    German drug assessment body not convinced by Bayers cancer drug Vitrakvi

    German drug assessment body not convinced by Bayer's cancer drug Vitrakvi

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok